Cabozantinib

Quiénes somos

• 5 de abril de 2022

  Protocolo de redescubrimiento de fármacos (ensayo DRUP)

• 5 de abril de 2022

  Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer

• 5 de abril de 2022

  Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors